Advertisement
Advertisement
U.S. markets open in 2 hours 59 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Athenex, Inc. (ATNX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.2826+0.0176 (+6.64%)
At close: 04:00PM EDT
0.2949 +0.01 (+4.35%)
Pre-Market: 06:28AM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Inside Bar (Bullish)

Inside Bar (Bullish)

Previous Close0.2650
Open0.2628
Bid0.0000 x 3200
Ask0.0000 x 900
Day's Range0.2620 - 0.2894
52 Week Range0.2250 - 3.0400
Volume1,011,458
Avg. Volume1,930,228
Market Cap44.39M
Beta (5Y Monthly)1.07
PE Ratio (TTM)N/A
EPS (TTM)-1.7760
Earnings DateNov 02, 2022 - Nov 07, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.33
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ATNX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Athenex, Inc.
    Daily – Vickers Top Insider Picks for 12/29/2021The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
    Rating
    Fair Value
    Economic Moat
    9 months agoArgus Research
View more
  • GlobeNewswire

    Athenex to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

    BUFFALO, N.Y., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Athenex (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that management will present at the H.C. Wainwright 24th Annual Global Investment Conference, taking place September 12-14, 2022, in New York, NY and virtually. Company management will also be available for one-on-one investor meetings durin

  • Simply Wall St.

    Do Insiders Own Lots Of Shares In Athenex, Inc. (NASDAQ:ATNX)?

    Every investor in Athenex, Inc. ( NASDAQ:ATNX ) should be aware of the most powerful shareholder groups. Large...

  • GlobeNewswire

    Athenex, Inc. Announces Pricing of $30 Million Public Offering of Common Stock and Warrants

    BUFFALO, N.Y., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc. (“Athenex”) (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced the pricing of its underwritten public offering of 35,333,334 shares of its common stock and accompanying warrants to purchase up to 35,333,334 shares of common stock at a combined public offering price of $0.75 per share an

Advertisement
Advertisement